RE: NO Pump Required17 Mar 2025 21:00
Dr Darrin M Disley OBE, currently a Non-Executive Director, will be appointed Interim Managing Director with effect from close of business on 17 March 2025.
Darrin Disley is a seasoned life sciences entrepreneur with a history of value creation in the UK market. His most notable achievement is leading gene editing company Horizon Discovery from start-up phase in 2007 to a £68 million AIM IPO in 2014 and growing the business to generate significant revenues with a global presence before stepping down to pursue other interests in 2018. Horizon was eventually acquired by PerkinElmer in 2021 for a total Enterprise value of £296 million. Roquefort Therapeutics is pleased to have Dr Disley leading the business and his significant expertise will be of benefit to the Company going forward.
😎